Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Developing processes to controllably dope transition-metal dichalcogenides (TMDs) is critical for optical and electrical applications. Here, molecular reductants and oxidants are introduced onto monolayer TMDs, specifically MoS , WS , MoSe , and WSe . Doping is achieved by exposing the TMD surface to solutions of pentamethylrhodocene dimer as the reductant (n-dopant) and "Magic Blue," [N(C H -p-Br) ]SbCl , as the oxidant (p-dopant). Current-voltage characteristics of field-effect transistors show that, regardless of their initial transport behavior, all four TMDs can be used in either p- or n-channel devices when appropriately doped. The extent of doping can be controlled by varying the concentration of dopant solutions and treatment time, and, in some cases, both nondegenerate and degenerate regimes are accessible. For all four TMD materials, the photoluminescence intensity; for all four materials the PL intensity is enhanced with p-doping but reduced with n-doping. Raman and X-ray photoelectron spectroscopy (XPS) also provide insight into the underlying physical mechanism by which the molecular dopants react with the monolayer. Estimates of changes of carrier density from electrical, PL, and XPS results are compared. Overall a simple and effective route to tailor the electrical and optical properties of TMDs is demonstrated.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6353705PMC
http://dx.doi.org/10.1002/adma.201802991DOI Listing

Publication Analysis

Top Keywords

controllable wide-ranging
4
wide-ranging n-doping
4
n-doping p-doping
4
p-doping monolayer
4
monolayer group
4
group transition-metal
4
transition-metal disulfides
4
disulfides diselenides
4
diselenides developing
4
developing processes
4

Similar Publications

Lemon balm (), a perennial herb belonging to the Lamiaceae family, is widely recognized for its medicinal properties and therapeutic benefits. This review offers a detailed exploration of the botanical features, phytochemical composition, and pharmacological uses of , highlighting key bioactive compounds such as phenolic acids (including rosmarinic and caffeic acids), flavonoids, essential oils (such as citral and citronellal), and triterpenoids (ursolic and oleanolic acids). Advanced extraction techniques, such as ultrasound-assisted extraction (UAE), microwave-assisted extraction (MAE), pressurized liquid extraction (PLE), supercritical fluid extraction (SFE), and matrix solid-phase dispersion (MSPD), have greatly improved the efficiency of extraction, the preservation of bioactivity, and the sustainability of acquiring these bioactive compounds.

View Article and Find Full Text PDF

Liraglutide is a key therapeutic agent in managing type 2 diabetes mellitus (T2DM), with benefits extending beyond glycemic control to address cardiovascular and renal comorbidities. As T2DM prevalence rises globally, the need for medications that provide comprehensive health benefits becomes increasingly important. Liraglutide, a GLP-1 receptor agonist, has demonstrated effectiveness in reducing cardiovascular events, especially among patients with high cardiovascular risk, such as those with a prior history of myocardial infarction or stroke.

View Article and Find Full Text PDF

Objectives: Status epilepticus (SE) is a life-threatening neurologic emergency. Although health disparities in epilepsy are well-documented, disparities in SE mortality are not fully understood. This study analyzes mortality trends and demographics in the United States from 1999 through 2020.

View Article and Find Full Text PDF

Background: Cardiac Conduction Disorders (CCDs) in young adults aged 25-44 years represent an important and poorly investigated condition associated with death.

Objective: We assessed trends in CCD-associated mortality in the United States (US) from 2010 to 2020 among young adults to determine differences by sex, ethno-racial groups, urbanization, census region, and underlying causes of death.

Methods: Mortality data were obtained from the Centers for Disease Control and Prevention Wide-Ranging Online Data for Epidemiologic Research database, covering the period from 2010 to 2020.

View Article and Find Full Text PDF

Background: Autopsy, the gold standard for determining the cause of death, is declining globally. Significant differences exist between clinical diagnoses and those revealed at autopsy. Evidence of disparities in autopsy rates between different patient groups has previously been reported.

View Article and Find Full Text PDF